Health Benefits of Blue-Green Algae: Prevention of Cardiovascular Disease and Nonalcoholic Fatty Liver Disease

被引:57
作者
Ku, Chai Siah [1 ]
Yang, Yue [1 ]
Park, Youngki [1 ]
Lee, Jiyoung [1 ]
机构
[1] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA
关键词
antioxidant; blue-green algae; cardiovascular disease; cholesterol; inflammation; nonalcoholic fatty liver disease; NF-KAPPA-B; STEROL REGULATORY ELEMENT; LIPOPROTEIN RECEPTOR PROMOTER; REDUCING OXIDATIVE STRESS; APHANIZOMENON-FLOS-AQUAE; HIGH-CHOLESTEROL DIET; C-PHYCOCYANIN; SPIRULINA-MAXIMA; NOSTOC-COMMUNE; ATHEROSCLEROTIC LESION;
D O I
10.1089/jmf.2012.2468
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Blue-green algae (BGA) are among the most primitive life forms on earth and have been consumed as food or medicine by humans for centuries. BGA contain various bioactive components, such as phycocyanin, carotenoids, gamma-linolenic acid, fibers, and plant sterols, which can promote optimal health in humans. Studies have demonstrated that several BGA species or their active components have plasma total cholesterol and triglyceride-lowering properties due to their modulation of intestinal cholesterol absorption and hepatic lipogenic gene expression. BGA can also reduce inflammation by inhibiting the nuclear factor kappa B activity, consequently reducing the production of proinflammatory cytokines. Furthermore, BGA inhibit lipid peroxidation and have free radical scavenging activity, which can be beneficial for the protection against oxidative stress. The aforementioned effects of BGA can contribute to the prevention of metabolic and inflammatory diseases. This review provides an overview of the current knowledge of the health-promoting functions of BGA against cardiovascular disease and nonalcoholic fatty liver disease, which are major health threats in the developed countries.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 96 条
[1]  
[Anonymous], 2010, J MED CASE REP, DOI DOI 10.1186/1752-1947-4-103
[2]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[3]  
Bashandy SA, 2011, AFR J PHARM PHARMACO, V5, P175
[4]   Antioxidant properties of a novel phycocyanin extract from the blue-green alga Aphanizomenon flos-aquae [J].
Benedetti, S ;
Benvenuti, F ;
Pagliarani, S ;
Francogli, S ;
Scoglio, S ;
Canestrari, F .
LIFE SCIENCES, 2004, 75 (19) :2353-2362
[5]   Oxygen Radical Absorbance Capacity of Phycocyanin and Phycocyanobilin from the Food Supplement Aphanizomenon flos-aquae [J].
Benedetti, Serena ;
Benvenuti, Francesca ;
Scoglio, Stefano ;
Canestrari, Franco .
JOURNAL OF MEDICINAL FOOD, 2010, 13 (01) :223-227
[6]   PHYCOCYANIN IN PHYSICAL-CHEMICAL STUDIES [J].
BERNS, DS ;
MACCOLL, R .
CHEMICAL REVIEWS, 1989, 89 (04) :807-825
[7]   Lipid control in patients with diabetes mellitus [J].
Betteridge, D. John .
NATURE REVIEWS CARDIOLOGY, 2011, 8 (05) :278-290
[8]   C-Phycocyanin:: A potent peroxyl radical scavenger in vivo and in vitro [J].
Bhat, VB ;
Madyastha, KM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (01) :20-25
[9]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[10]  
BRIGGS MR, 1993, J BIOL CHEM, V268, P14490